Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Official title: Response of Cartilage Degradation Biomarkers to Acute Mechanical Loading and the Effect of Antiresorptive Therapy in Postmenopausal Women With Mild-to-Moderate Knee Osteoarthritis
Run by Sisli Hamidiye Etfal Training and Research Hospital · NCT07881861 · Data updated 2026-11-12
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years to 80 Years |
| Sex | Women only |
| Enrollment | 105 (estimated) |
| Sponsor | Sisli Hamidiye Etfal Training and Research Hospital Academic / other |
| Drugs / interventions | prednisone, denosumab |
| Locations | 1 site (Istanbul, Istanbul) |
| Status | Recruiting |
| Started | May 8, 2026 |
| Main results expected | February 10, 2027 |
| Study ends | February 10, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07881861 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Postmenopausal women aged 60–80 with DEXA-confirmed osteoporosis or osteopenia and radiographically confirmed knee OA (Kellgren-Lawrence grade 2 or 3).
✕Probably not a fit
Patients not responsive to mechanical loading in terms of biomarker changes or those outside the antiresorptive groups may see no demonstrated benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study groups postmenopausal women with mild-to-moderate knee OA by antiresorptive treatment status and subjects them to a standardized 30-minute treadmill walk. Blood samples taken just before and within 2 minutes after walking will be analyzed for cartilage degradation biomarkers such as COMP and MMP-3. The goal is to see if the biomarker response to acute mechanical loading differs based on antiresorptive therapy. Eligible participants are between 60 and 80 years old, with osteoporosis or osteopenia, and imaging-confirmed knee OA (K/L grades 2–3). No interventional treatment is being tested; the study observes natural biomarker changes in relation to existing medications.
Why it matters
Potential benefit: If successful, findings could help tailor exercise recommendations and clarify how antiresorptive therapies influence cartilage health responses to loading.
How similar studies have gone: Prior work has explored how mechanical loading and biomarkers relate to cartilage health, but this study's stratification by antiresorptive status is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postmenopausal women aged 60-80 years. * DEXA-confirmed diagnosis of osteoporosis or osteopenia. * Clinically and radiographically confirmed knee osteoarthritis, with Kellgren-Lawrence grade 2 or 3 in at least one knee. * Knee MRI performed within the previous 3 months. * Bilateral hand radiographs performed within the previous 6 months. * Pain intensity of at least 20 mm on the Visual Analog Scale (VAS) during activity. * Ability to tolerate the standardized acute mechanical loading protocol consisting of 30 minutes of treadmill walking. * Non-sarcopenic status according to the STAR protocol. * Ability to provide written informed consent. Exclusion Criteria: * Inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. * Active gout or calcium pyrophosphate deposition (CPPD) attack. * History of total knee arthroplasty or major knee surgery. * Intra-articular knee injection within the previous 12 months. * Change in antiresorptive therapy within the previous 6 months. * Previous osteoanabolic therapy. * Systemic corticosteroid use for ≥3 months at a dose equivalent to ≥5 mg/day of prednisone. * Glomerular filtration rate (eGFR) \<30 mL/min. * New York Heart Association (NYHA) class III-IV heart failure. * Uncontrolled diabetes mellitus or hypertension. * Neurological disease significantly limiting walking. * Cognitive impairment.
Where it's running
-
Sisli Hamidiye Etfal Training and Research Hospital
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
-
Differences in Functional Capacity in Knee Osteoarthritis with Similar Pain
This study tests factors that might explain why people with knee osteoarthritis and similar pain levels have different abilities to walk, stand, and perform daily tasks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.